Archive for May 19th, 2011

CORT additional Phase 3 CORLUX data to be presented June 4 + OMER INFI

May 19, 2011 No Comments by

Corcept Therapeutics Incorporated (NASDAQ: CORT), today announced that detailed data from the Phase 3 study of CORLUX in Cushings Syndrome will be presented at the Endocrine Society 93rd Annual Meeting (ENDO) held June 4 – 7, 2011 in Boston. On April 15, 2011, they submitted their NDA. The abstract (No. OR09-5) will be presented on […]

Daily News Read more

ASCO 2011 Abstracts have been added to the ASCO Calendar

May 19, 2011 No Comments by

The BioPharmCatalyst ASCO 2011 Calendar has been completed with the addition of ALL abstracts of companies that were originally listed on the calendar. Just click on the ASCO tab above and you will find that abstracts have been added by clicking on the Abstract Link number. There are many companies that are just presenting previously […]

Articles Read more